Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS

Savita G Pahwa, K. Biron, W. Lim, P. Swenson, M. H. Kaplan, N. Sadick, Rajendra Pahwa

Research output: Contribution to journalArticle

130 Citations (Scopus)

Abstract

Acyclovir has become the treatment of choice for varicella-zoster virus (VZV) infections in immunocompromised individuals. This article describes a 4-year-old girl congenitally infected with human immunodeficiency virus who developed a continuous cutaneous infection with VZV that persisted over a 14-month period until her death. Initial episodes of varicella zoster were responsive to acyclovir treatment; however, subsequent recurrences necessitated administration of multiple courses of acyclovir. Lesions became markedly hyperkeratotic, slow healing, and persistent despite acyclovir therapy. Numerous attempts to isolate virus from the lesions yielded only one isolate late in the course of therapy. This virus clearly demonstrated acyclovir resistance in vitro. Bizarre manifestations of VZV infection could present both diagnostic and therapeutic dilemmas. Prolonged acyclovir treatment of highly immunocompromised patients with acquired immunodeficiency syndrome and severe VZV may lead to the appearance of resistant virus.

Original languageEnglish
Pages (from-to)2879-2882
Number of pages4
JournalJournal of the American Medical Association
Volume260
Issue number19
StatePublished - Jan 1 1988
Externally publishedYes

Fingerprint

Acyclovir
Chickenpox
Herpes Zoster
Acquired Immunodeficiency Syndrome
Human Herpesvirus 3
Infection
Virus Diseases
Viruses
Therapeutics
Immunocompromised Host
HIV
Recurrence
Skin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pahwa, S. G., Biron, K., Lim, W., Swenson, P., Kaplan, M. H., Sadick, N., & Pahwa, R. (1988). Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS. Journal of the American Medical Association, 260(19), 2879-2882.

Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS. / Pahwa, Savita G; Biron, K.; Lim, W.; Swenson, P.; Kaplan, M. H.; Sadick, N.; Pahwa, Rajendra.

In: Journal of the American Medical Association, Vol. 260, No. 19, 01.01.1988, p. 2879-2882.

Research output: Contribution to journalArticle

Pahwa, SG, Biron, K, Lim, W, Swenson, P, Kaplan, MH, Sadick, N & Pahwa, R 1988, 'Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS', Journal of the American Medical Association, vol. 260, no. 19, pp. 2879-2882.
Pahwa, Savita G ; Biron, K. ; Lim, W. ; Swenson, P. ; Kaplan, M. H. ; Sadick, N. ; Pahwa, Rajendra. / Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS. In: Journal of the American Medical Association. 1988 ; Vol. 260, No. 19. pp. 2879-2882.
@article{bbd753a700d441fe81d13218cf82b68a,
title = "Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS",
abstract = "Acyclovir has become the treatment of choice for varicella-zoster virus (VZV) infections in immunocompromised individuals. This article describes a 4-year-old girl congenitally infected with human immunodeficiency virus who developed a continuous cutaneous infection with VZV that persisted over a 14-month period until her death. Initial episodes of varicella zoster were responsive to acyclovir treatment; however, subsequent recurrences necessitated administration of multiple courses of acyclovir. Lesions became markedly hyperkeratotic, slow healing, and persistent despite acyclovir therapy. Numerous attempts to isolate virus from the lesions yielded only one isolate late in the course of therapy. This virus clearly demonstrated acyclovir resistance in vitro. Bizarre manifestations of VZV infection could present both diagnostic and therapeutic dilemmas. Prolonged acyclovir treatment of highly immunocompromised patients with acquired immunodeficiency syndrome and severe VZV may lead to the appearance of resistant virus.",
author = "Pahwa, {Savita G} and K. Biron and W. Lim and P. Swenson and Kaplan, {M. H.} and N. Sadick and Rajendra Pahwa",
year = "1988",
month = "1",
day = "1",
language = "English",
volume = "260",
pages = "2879--2882",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "19",

}

TY - JOUR

T1 - Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS

AU - Pahwa, Savita G

AU - Biron, K.

AU - Lim, W.

AU - Swenson, P.

AU - Kaplan, M. H.

AU - Sadick, N.

AU - Pahwa, Rajendra

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Acyclovir has become the treatment of choice for varicella-zoster virus (VZV) infections in immunocompromised individuals. This article describes a 4-year-old girl congenitally infected with human immunodeficiency virus who developed a continuous cutaneous infection with VZV that persisted over a 14-month period until her death. Initial episodes of varicella zoster were responsive to acyclovir treatment; however, subsequent recurrences necessitated administration of multiple courses of acyclovir. Lesions became markedly hyperkeratotic, slow healing, and persistent despite acyclovir therapy. Numerous attempts to isolate virus from the lesions yielded only one isolate late in the course of therapy. This virus clearly demonstrated acyclovir resistance in vitro. Bizarre manifestations of VZV infection could present both diagnostic and therapeutic dilemmas. Prolonged acyclovir treatment of highly immunocompromised patients with acquired immunodeficiency syndrome and severe VZV may lead to the appearance of resistant virus.

AB - Acyclovir has become the treatment of choice for varicella-zoster virus (VZV) infections in immunocompromised individuals. This article describes a 4-year-old girl congenitally infected with human immunodeficiency virus who developed a continuous cutaneous infection with VZV that persisted over a 14-month period until her death. Initial episodes of varicella zoster were responsive to acyclovir treatment; however, subsequent recurrences necessitated administration of multiple courses of acyclovir. Lesions became markedly hyperkeratotic, slow healing, and persistent despite acyclovir therapy. Numerous attempts to isolate virus from the lesions yielded only one isolate late in the course of therapy. This virus clearly demonstrated acyclovir resistance in vitro. Bizarre manifestations of VZV infection could present both diagnostic and therapeutic dilemmas. Prolonged acyclovir treatment of highly immunocompromised patients with acquired immunodeficiency syndrome and severe VZV may lead to the appearance of resistant virus.

UR - http://www.scopus.com/inward/record.url?scp=0023685670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023685670&partnerID=8YFLogxK

M3 - Article

C2 - 3184352

AN - SCOPUS:0023685670

VL - 260

SP - 2879

EP - 2882

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 19

ER -